What is BofA Securities's price target for HIMS?

BofA Securities's latest stated price target for Hims & Hers Health Inc. (HIMS) is $23, from its action on Mar 10, 2026.

What is BofA Securities's rating on HIMS?

BofA Securities rates HIMS Neutral, a neutral rating, as of Mar 10, 2026.

When did BofA Securities last change its view on HIMS?

On Mar 10, 2026, BofA Securities upgrades to Neutral from Underperform, price target $23.

Analyst firms · BofA Securities · HIMS

BofA Securities HIMS price target and rating history

Hims & Hers Health Inc. (HIMS) · Health Care

BofA Securities rates Hims & Hers Health Inc. (HIMS) Neutral with a $23 price target, as of its latest action on Mar 10, 2026. It has published 4 rating actions on HIMS since July 2021, including 2 upgrades and 1 downgrade. Across 5 firms with a HIMS price target in the last 12 months, the median target is $33. BofA Securities's $23 is 30% below that.

Current rating: Neutral
Price target: $23
Median target, all firms: $33
Actions on HIMS: 4

BofA Securities price target on HIMS

BofA Securities price target on HIMS, each point a stated target, July 2021 to March 2026.

Every BofA Securities rating on HIMS

Mar 10, 2026
UpgradeBofA Securities upgrades to Neutral from Underperform, price target $23
Nov 14, 2024
DowngradeBofA Securities downgrades to Underperform from Buy
Nov 8, 2022
UpgradeBofA Securities upgrades to Buy from Neutral, price target $7.50 to $8.50
Jul 6, 2021
InitiateBofA Securities starts coverage at Neutral, price target $12

How other firms rate HIMS

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Needham	Buy	$35	May 12, 2026
Citigroup	Neutral	$24	Mar 10, 2026
BofA Securities	Neutral	$23	Mar 10, 2026
BTIG	Neutral		Feb 24, 2026
Evercore ISI	In-line	$33	Jan 12, 2026
Barclays	Overweight	$48	Dec 9, 2025

Questions about BofA Securities and HIMS

What is BofA Securities's price target for HIMS?: BofA Securities's latest stated price target for Hims & Hers Health Inc. (HIMS) is $23, from its action on Mar 10, 2026.
What is BofA Securities's rating on HIMS?: BofA Securities rates HIMS Neutral, a neutral rating, as of Mar 10, 2026.
When did BofA Securities last change its view on HIMS?: On Mar 10, 2026, BofA Securities upgrades to Neutral from Underperform, price target $23.
How does BofA Securities's HIMS target compare with other analysts?: Across 5 firms with a HIMS price target in the last 12 months, the median target is $33. BofA Securities's $23 is 30% below that.

More HIMS rating histories

All BofA Securities ratings HIMS news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.